Docosahexaenoic Acid Controls Pulmonary Macrophage Lipid Raft Size and Inflammation.

Area of Science:

• Cell Biology
• Immunology
• Biophysics

Background:

• Docosahexaenoic acid (DHA) is known to modulate plasma membrane organization and exert anti-inflammatory effects, particularly in lymphocytes.
• The specific impact of DHA on alveolar macrophage lipid rafts and subsequent inflammation remains largely uncharacterized.

Purpose of the Study:

• To investigate how DHA influences the organization and function of lipid rafts in alveolar macrophages.
• To explore the anti-inflammatory effects of DHA in a murine model of influenza.

Main Methods:

• Utilized MH-S cells (alveolar macrophage line) treated with DHA to analyze plasma membrane organization via fluorescence methods.
• Employed biomimetic membranes and molecular dynamics (MD) simulations to understand DHA's mechanism in controlling lipid raft size.
• Quantified inflammatory markers using qRT-PCR, mass spectrometry, and ELISAs, and analyzed lung tissues from an influenza mouse model.

Main Results:

• DHA increased lipid raft size and decreased plasma membrane molecular packing in MH-S cells.
• MD simulations indicated DHA nucleates lipid rafts by promoting cholesterol and sphingomyelin aggregation.
• DHA treatment reduced inflammatory signaling molecules, including IL-6, and decreased pulmonary Il6 and Tnf-α mRNA expression in influenza-infected mice.

Conclusions:

• DHA promotes the formation of larger lipid rafts by influencing cholesterol and sphingomyelin localization, which may inhibit inflammatory signaling.
• Alveolar macrophages are identified as a cellular target for DHA's anti-inflammatory actions.
• DHA demonstrates significant potential in mitigating lung inflammation, particularly in the context of viral infections.